4//SEC Filing
Veitch David 4
Accession 0001181431-13-015380
CIK 0000722104other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:50 PM ET
Size
7.6 KB
Accession
0001181431-13-015380
Insider Transaction Report
Form 4
Veitch David
Pres, Savient Pharma Ireland
Transactions
- Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 totalExercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying) - Award
Option to Purchase Common Stock
2013-03-05+162,500→ 162,500 totalExercise: $0.94Exp: 2022-01-16→ Common Stock (162,500 underlying)
Footnotes (2)
- [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
- [F2]These options were granted pursuant to the terms of Mr. Veitch's employment and vest as follows: 25% on the first anniversary of his commencement date, January 16, 2012, and an additional 6.25% at the end of each successive three-month period following the first anniversary,
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001539762
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:50 PM ET
- Size
- 7.6 KB